# An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System

> **NCT04198012** · NA · COMPLETED · sponsor: **Deka Research and Development** · enrollment: 25 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** HemoCare™ Hemodialysis System

## Key facts

- **NCT ID:** NCT04198012
- **Lead sponsor:** Deka Research and Development
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-04-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04198012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04198012, "An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04198012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*